Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma;Erfahrungen mit der neuen Americana Joint Committee on Cancer (AJCC)-klassifikation des kutanen malignen melanoms

JDDG - Journal of the German Society of Dermatology

Volumn 3, Issue 8, 2005, Pages 592-598

  Eigentler, Thomas K ^a   Radny, Peter ^a   Kamin, Anne ^a   Weide, Benjamin ^a   Caroli, Ulrich M ^a   Garbe, Claus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Classification; Cutaneous melanoma; Prognosis; Staging

Indexed keywords

CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER STAGING; HEALTH CARE ORGANIZATION; HUMAN; MELANOMA; METASTASIS; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE BIOPSY; TUMOR; CANCER INVASION; CLASSIFICATION; COMPARATIVE STUDY; GERMANY; LUNG TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; METHODOLOGY; MORTALITY; PATHOLOGY; REGISTER; SKIN TUMOR; TIME; UNITED STATES;

GERMANY; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; REGISTRIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TIME FACTORS; UNITED STATES;

EID: 26944472838     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2005.05051.x     Document Type: Review

References (23)

1. Carlson JA, Slominski A, Linette GP, Mysliborski J, Hill J, Mihm MC Jr, Ross JS: Malignant melanoma 2003. predisposition, diagnosis, prognosis, and staging. Am J Clin Pathol 2003; 120 Suppl: S101-S127.
2. American Cancer Society. Cancer facts & figures. http://www.cancer. org/downloads/STT/CAFF_finalPWSecur-ed.pdf. 2004. Atlanta, American Cancer Society. 29-4-2004.
3. Ahmed I. Malignant melanoma: prognostic indicators. Mayo Clin Proc 1997: 72: 356-361.
4. Krown SE, Chapman PB. Defining adequate surgery for primary melanoma. N Engl J Med 2004; 350: 823-825.
5. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM, Atkins MB, Thompson JA, Coit DG, Byrd D, Desmond R, Zhang Y, Liu PY, Lyman GH, Morabito A. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19: 3622-3634.
6. Eigentler TK, Caroli UM, Radny P, Garbe C. Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials. Lancet Oncology 2003; 4: 748-759.
7. Buzaid AC, Ross MI, Balch CM, Soong S, McCarthy WH, Tinoco L, Mansfield P, Lee JE, Bedikian A, Eton O, Plager C, Papadopoulos N, Legha SS, Benjamin RS. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol 1997; 15: 1039-1051.
8. Fleming ID, Cooper JS, Henson DE. AJCC Cancer Staging Manual Philadelphia, Lippincott-Raven, 1997.
9. Thompson JA. The revised American Joint Committee on Cancer staging system for melanoma. Semin Oncol 2002; 29: 361-369.
10. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902-908.
11. Leiter U, Büttner P, Eigentler TK, Garbe C. Prognostic factors of thin cutaneous melanoma with 1 mm or less in tumor thickness. An analysis of the German Central Malignant Melanoma Registry of the German Dermatological Society. J Clin Oncol 2004; 22: 3660-3667.
12. Buzaid AC, Anderson CM. The changing prognosis of melanoma. Curr Oncol Rep 2000; 2: 322-328.
13. Büttner P, Garbe C, Bertz J, Burg G, d'Hoedt B, Drepper H, Guggenmoos-Holzmann I, Lechner W, Lippold A, Orfanos CE. Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. Cancer 1995; 75: 2499-2506.
14. Spatz A, Cook MG, Elder DE, Piepkorn M, Ruiter DJ, Barnhill RL. Interobserver reproducibility of ulceration assessment in primary cutaneous melanomas. Eur J Cancer 2003; 39: 1861-1865.
15. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635-3648.
16. Allen AC, Spitz S. Malignant melanoma; a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer 1953; 6: 1-45.
17. Tompkins V. Cutaneous melanoma: ulceration as a prognostic sign. Cancer 1953; 6: 1215-1218.
18. Vollmer R. Malignant melanoma: a multivariate analysis of prognostic factors. Pathol Annu 1989; 24: 383-407.
19. Eigentler TK, Buettner PG, Leiter U, Garbe C. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry. J Clin Oncol 2004; 22: 4376-4383.
20. Kim SH, Garcia C, Rodriguez J, Coit DG. Prognosis of thick cutaneous melanoma. J Am Coll Surg 1999; 188: 241-247.
21. Hermanek P, Hutter RV, Sobin LH, Wittekind C. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 1999; 86: 2668-2673.
22. Carlson GW, Murray DR, Lyles RH, Staley CA, Hestley A, Cohen C. The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance? Ann Surg Oncol 2003; 10: 575-581.
23. Mohammed MQ, Abraha HD, Sherwood RA, MacRae K, Retsas S. Serum S100beta protein as a marker of disease activity in patients with malignant melanoma. Med Oncol 2001; 18: 109-120.